Literature DB >> 20016069

Uncoupling of the spindle-checkpoint and chromosome-congression functions of BubR1.

Sabine Elowe1, Kalyan Dulla, Andreas Uldschmid, Xiuling Li, Zhen Dou, Erich A Nigg.   

Abstract

The BubR1 checkpoint protein performs multiple functions in mitosis. We have carried out a functional analysis of conserved motifs of human BubR1 (also known as BUB1B) and demonstrate that spindle assembly checkpoint (SAC) and chromosome attachment functions can be uncoupled from each other. Mutation of five proline-directed serine phosphorylation sites, identified in vivo by mass spectrometry, essentially abolishes attachment of chromosomes to the spindle but has no effect on SAC functionality. By contrast, mutation of the two conserved KEN boxes required for SAC function does not impact chromosome congression. Interestingly, the contribution of the two KEN-box motifs is not equal. Cdc20 associates with the N-terminal but not C-terminal KEN box, and mutation of the N-terminal KEN motif results in more severe acceleration of mitotic timing. Moreover, the two KEN motifs are not sufficient for maximal binding of Cdc20 and APC/C, which also requires sequences in the BubR1 C-terminus. Finally, mutation of the GLEBS motif causes loss of Bub3 interaction and mislocalization of BubR1 from the kinetochore; concomitantly, BubR1 phosphorylation as well as SAC activity and chromosome congression are impaired, indicating that the GLEBS motif is strictly required for both major functions of human BubR1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20016069     DOI: 10.1242/jcs.056507

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  60 in total

1.  Checkpoint-independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells.

Authors:  Lilian Kabeche; Duane A Compton
Journal:  Curr Biol       Date:  2012-03-08       Impact factor: 10.834

2.  Closed MAD2 (C-MAD2) is selectively incorporated into the mitotic checkpoint complex (MCC).

Authors:  Aaron R Tipton; Michael Tipton; Tim Yen; Song-Tao Liu
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

3.  Cohesin and Cdk1: an anaphase barricade.

Authors:  Keith T Jones
Journal:  Nat Cell Biol       Date:  2010-02       Impact factor: 28.824

4.  All together now: Polo joins the kinase network controlling the spindle assembly checkpoint in Drosophila.

Authors:  Carlos Conde; Mariana Osswald; Claudio E Sunkel
Journal:  Fly (Austin)       Date:  2013-08-29       Impact factor: 2.160

5.  An Inhibitor of PIDDosome Formation.

Authors:  Ruth Thompson; Richa B Shah; Peter H Liu; Yogesh K Gupta; Kiyohiro Ando; Aneel K Aggarwal; Samuel Sidi
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

Review 6.  Bub1 and BubR1: at the interface between chromosome attachment and the spindle checkpoint.

Authors:  Sabine Elowe
Journal:  Mol Cell Biol       Date:  2011-05-31       Impact factor: 4.272

7.  Defining the molecular basis of BubR1 kinetochore interactions and APC/C-CDC20 inhibition.

Authors:  Sheena D'Arcy; Owen R Davies; Tom L Blundell; Victor M Bolanos-Garcia
Journal:  J Biol Chem       Date:  2010-03-10       Impact factor: 5.157

Review 8.  Playing polo during mitosis: PLK1 takes the lead.

Authors:  G Combes; I Alharbi; L G Braga; S Elowe
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

Review 9.  Centromeres and kinetochores of Brassicaceae.

Authors:  Inna Lermontova; Michael Sandmann; Dmitri Demidov
Journal:  Chromosome Res       Date:  2014-06       Impact factor: 5.239

10.  Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.

Authors:  Yu Ding; Christopher G Hubert; Jacob Herman; Philip Corrin; Chad M Toledo; Kyobi Skutt-Kakaria; Julio Vazquez; Ryan Basom; Bin Zhang; Jennifer K Risler; Steven M Pollard; Do-Hyun Nam; Jeffery J Delrow; Jun Zhu; Jeongwu Lee; Jennifer DeLuca; James M Olson; Patrick J Paddison
Journal:  Cancer Discov       Date:  2012-11-15       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.